December 7, 2023 — Ajax Health announced today the formation and funding of Cortex, a medical technology company developing an integrated mapping and ablation solution suite for the treatment of atrial fibrillation (AFib), the most common heart rhythm disorder, affecting more than 30 million patients worldwide.

December 6, 2023 — The American Medical Association (AMA) released new 

December 5, 2023 — Raymond Benza, MD, FACC, FAHA, FACP, a top expert in cardiovascular medicine and advanced heart failure and transplantation, has been named Director of Pulmonary Hypertension for the Mount Sinai Health System. In this newly created position, Dr.

December 5, 2023 — David Epstein, MD, a pediatrician who has dedicated his career to caring for very ill children, has been selected as the new director of Pediatric and Congenital Cardiac Intensive Care at Cedars-Sinai Guerin Children’s.


November was a busy month with many FDA approvals and breaking clinical trial results. Take a look at the news making top headlines that you might have missed during the month of November.

1. BLOG: Cryoablation Gets New Tech


December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular research organization, has announced the publication of original research focused on health equity and outcomes in the fourth trimester of pregnancy (defined as the first 12 weeks postpartum/after delivery).


Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence in the United States of approximately 7% in people 20 years and older (1).


December 1, 2023 — As the use of wearable technology grows, smartwatches are marketed across the globe to consumers as a way to monitor health. 

For some, they’re told by these devices that they have atrial fibrillation, an irregular heartbeat, which is known to increase the risk of heart attack and stroke. 

December 1, 2023 — Researchers have succeeded in restoring lost brain function in mouse models of stroke using small molecules that in the future could potentially be developed into a stroke recovery therapy.

Subscribe Now